|
Year
|
Beginning Price
|
Ending Price
|
Gain or Loss
|
Percent Gain or Loss
|
|
1994
|
19.50
|
8.25
|
-11.25
|
-57.69%
|
|
1995
|
8.25
|
10.00
|
1.75
|
21.21%
|
|
1996
|
10.00
|
9.125
|
-0.875
|
-8.75%
|
|
1997
|
9.125
|
8.50
|
-0.625
|
-6.85%
|
|
1998
|
8.50
|
6.00
|
-2.50
|
-29.41%
|
|
1999
|
6.00
|
12.8125
|
6.8125
|
113.54%
|
|
2000
|
12.8125
|
22.8125
|
10.00
|
78.05%
|
|
2001
|
22.8125
|
23.24
|
0.4275
|
1.87%
|
|
2002
|
23.24
|
11.151
|
-12.089
|
-52.02%
|
|
2003
|
11.151
|
12.79
|
1.639
|
14.70%
|
|
2004
|
12.79
|
8.10
|
-4.69
|
-36.67%
|
|
2005
|
8.10
|
5.93
|
-2.17
|
-26.79%
|
|
2006
|
5.93
|
3.39
|
-2.54
|
-42.83%
|
|
2007
|
3.39
|
2.30
|
-1.09
|
-32.15%
|
|
2008
|
2.30
|
0.22
|
-2.08
|
-90.43%
|
|
2009
|
0.22
|
0.2342
|
-0.0142
|
-6.45%
|
*In 2009, Cell Genesys was purchased by Bio Sante and shareholders received .1615 shares of Bio Sante stock for each share of CEGE.